SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-161716
Filing Date
2024-06-14
Accepted
2024-06-14 17:11:24
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d742037d424b5.htm 424B5 348590
2 EX-FILING FEES d742037dexfilingfees.htm EX-FILING FEES 26013
3 GRAPHIC g742037g13p11.jpg GRAPHIC 79403
4 GRAPHIC g742037g16t54.jpg GRAPHIC 84672
  Complete submission text file 0001193125-24-161716.txt   601902
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-277226 | Film No.: 241045921
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)